<DOC>
	<DOC>NCT01907997</DOC>
	<brief_summary>Systemic lidocaine infusion may improve the patients' recovery quality and chronic post surgical pain after robot-assisted thyroidectomy</brief_summary>
	<brief_title>Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Age between 2065 ASA class I and II Thyroid cancer patients who are scheduled for elective robotassisted thyroidectomy Allergy to local anesthetics or contraindication to use of lidocaine Pregnancy Severe cardiovascular disease Renal failure Liver failure Neurologic and psychologic disease Chronic treatment with analgesics</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer</keyword>
</DOC>